- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 7/10 - Antioedematous agents; Diuretics
Patent holdings for IPC class A61P 7/10
Total number of patents in this class: 426
10-year publication summary
27
|
15
|
21
|
27
|
22
|
38
|
41
|
32
|
22
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2945 |
17 |
Daiichi Sankyo Company, Limited | 1864 |
12 |
Merck Sharp & Dohme Corp. | 2219 |
8 |
scPharmaceuticals Inc. | 34 |
8 |
KalVista Pharmaceuticals Limited | 115 |
7 |
Memorial Sloan-Kettering Cancer Center | 1885 |
7 |
Taisho Pharmaceutical Co., Ltd. | 860 |
7 |
Astellas Pharma Inc. | 1122 |
5 |
BioMarin Pharmaceutical Inc. | 373 |
5 |
Kissei Pharmaceutical Co., Ltd. | 198 |
5 |
Santen Pharmaceutical Co., Ltd. | 626 |
5 |
Shanghai Xunhe Pharmaceutical Technology Co. Ltd. | 12 |
5 |
BioCryst Pharmaceuticals, Inc. | 176 |
4 |
Dyax Corp. | 106 |
4 |
Igisu Co., Ltd | 22 |
4 |
Ono Pharmaceutical Co., Ltd. | 436 |
4 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 805 |
4 |
Shiseido Company, Ltd. | 3960 |
4 |
Suntory Holdings Limited | 1968 |
4 |
RESQ Pharmaceuticals LLC | 8 |
4 |
Other owners | 303 |